Literature DB >> 19594418

Immunomodulatory and anti-inflammatory activities of statins.

Emilia Mira1, Santos Mañes.   

Abstract

The statins are a group of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase that are used extensively in medical practice because of their ability to reduce cardiovascular mortality and stroke. Although this protective activity was initially ascribed to the inhibition of cholesterol biosynthesis in the liver, clinical trials and basic research studies indicate that, beyond their cholesterol-lowering activity, statins might affect the function of different cell types in extrahepatic tissues. Here we will review the different mechanisms by which the statins exert their immunomodulatory and anti-inflammatory functions. We propose that statin pleiotropism is a key to the explanation of these activities, as it enables statins to act cooperatively in various steps of the inflammatory reaction, including terminal differentiation of immune cells, endothelial cell function, and regulation of the molecules that steer these cells to the sites at which they exert their immunomodulatory activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19594418     DOI: 10.2174/187153009789044383

Source DB:  PubMed          Journal:  Endocr Metab Immune Disord Drug Targets        ISSN: 1871-5303            Impact factor:   2.895


  20 in total

1.  Understanding gene expression in coronary artery disease through global profiling, network analysis and independent validation of key candidate genes.

Authors:  Prathima Arvind; Shanker Jayashree; Srikarthika Jambunathan; Jiny Nair; Vijay V Kakkar
Journal:  J Genet       Date:  2015-12       Impact factor: 1.166

2.  Simvastatin represses protein synthesis in the muscle-derived C₂C₁₂ cell line with a concomitant reduction in eukaryotic initiation factor 2B expression.

Authors:  Alexander P Tuckow; Sarah J Jefferson; Scot R Kimball; Leonard S Jefferson
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-01-11       Impact factor: 4.310

Review 3.  Pediatric Statin Administration: Navigating a Frontier with Limited Data.

Authors:  Jonathan Wagner; Susan M Abdel-Rahman
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Sep-Oct

Review 4.  The role of statins in the setting of HIV infection.

Authors:  Allison Ross Eckard; Grace A McComsey
Journal:  Curr HIV/AIDS Rep       Date:  2015-09       Impact factor: 5.071

5.  Atorvastatin and Simvastatin Promoted Mouse Lung Repair After Cigarette Smoke-Induced Emphysema.

Authors:  Vanessa Pinho-Ribeiro; Adriana Correa Melo; Emanuel Kennedy-Feitosa; Adriane Graca-Reis; Marina Valente Barroso; Isabella Cattani-Cavalieri; Giovanna Marcella Cavalcante Carvalho; Walter Araújo Zin; Luis Cristóvão Porto; Lycia Brito Gitirana; Manuella Lanzetti; Samuel Santos Valença
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

6.  Combined sub-optimal doses of rosuvastatin and bexarotene impair angiotensin II-induced arterial mononuclear cell adhesion through inhibition of Nox5 signaling pathways and increased RXR/PPARα and RXR/PPARγ interactions.

Authors:  Paula Escudero; Aranzazu Martinez de Marañón; Aida Collado; Herminia Gonzalez-Navarro; Carlos Hermenegildo; Concepción Peiró; Laura Piqueras; Maria-Jesus Sanz
Journal:  Antioxid Redox Signal       Date:  2015-03-09       Impact factor: 8.401

Review 7.  Novel Effects of Statins on Cancer via Autophagy.

Authors:  Daniela Mengual; Luz Elena Medrano; Wendy Villamizar-Villamizar; Estefanie Osorio-Llanes; Evelyn Mendoza-Torres; Samir Bolívar
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-24

Review 8.  Statins to improve cardiovascular outcomes in treated HIV infection.

Authors:  Chris T Longenecker; Allison R Eckard; Grace A McComsey
Journal:  Curr Opin Infect Dis       Date:  2016-02       Impact factor: 4.915

9.  Association between use of HMG CoA reductase inhibitors and mortality in HIV-infected patients.

Authors:  Richard D Moore; John G Bartlett; Joel E Gallant
Journal:  PLoS One       Date:  2011-07-12       Impact factor: 3.240

10.  A lovastatin-elicited genetic program inhibits M2 macrophage polarization and enhances T cell infiltration into spontaneous mouse mammary tumors.

Authors:  Emilia Mira; Lorena Carmona-Rodríguez; Manuel Tardáguila; Iñigo Azcoitia; Alicia González-Martín; Luis Almonacid; Josefina Casas; Gemma Fabriás; Santos Mañes
Journal:  Oncotarget       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.